← Signal Board

Anbio Biotechnology Class A Ordinary Shares financial statements

안비오 바이오테크놀로지NASDAQ:NNNN · Nasdaq
$4.90+0.00%
2026-10-07 close · prelim

Anbio Biotechnology Class A Ordinary Shares's published financial data is dated 2026-10-04. 2024 revenue was $8M. 2024 operating profit was $2M.

Reported results

Anbio Biotechnology Class A Ordinary Shares notifications

Quantus Signal · live data · not investment advice · Privacy Policy